Test Bank Abrams' Clinical Drug Therapy: Rationales for Nursing
Practice 13th Edition
By Geralyn Frandsen & Sandra Pennington
All Chapters (1-61) Q&A with Rationales| GRADE A+
ISBN 9781975222321
~1~
,THIS DOCUMENT BELONGS TO TESTBANKSPROF
TABLE OF CONTENTS
Chapter 1 : The Foundation of Pharmacology: Quality and Safety : ................................. 4
Chapter 2, Basic Concepts and Processes ....................................................................... 16
Chapter 3, Medication Administration and the Nursing Process of Drug Therapy ........ 28
Chapter 4, Pharmacology and the Care of Infants and Pediatric Patients ...................... 38
Chapter 5, Pharmacology and the Care of Adults and Geriatric Patients ....................... 48
Chapter 6, Pharmacology and the Care of Pregnant or Lactating Women ..................... 60
Chapter 7, Pharmacology and Women‘s Health ............................................................. 73
Chapter 8, Pharmacology and Men‘s Health ................................................................... 84
Chapter 9, Drug Therapy for Coagulation Disorders ...................................................... 97
Chapter 10, Drug Therapy for Dyslipidemia ................................................................ 108
Chapter 11, Drug Therapy for Hematopoietic Disorders ............................................. 119
Chapter 12, Drug Therapy: Immunizations .................................................................. 131
Chapter 13, Drug Therapy to Decrease Immunity ........................................................ 143
Chapter 14, Drug Therapy for the Treatment of Cancer ............................................... 154
Chapter 15, Inflammation, Infection, and the Use of Antimicrobial Agents ................. 166
Chapter 16, Drug Therapy to Decrease Pain, Fever, and Inflammation ........................ 178
Chapter 17, Drug Therapy With Corticosteroids .......................................................... 189
Chapter 18, Drug Therapy With Beta-Lactam Antibacterial Agents ............................ 201
Chapter 19, Drug Therapy With Aminoglycosides and Fluoroquinolones ................... 214
Chapter 20, Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics
...................................................................................................................................... 225
Chapter 21, Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents 237
Chapter 22, Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease
...................................................................................................................................... 247
Chapter 23, Drug Therapy for Viral Infections ............................................................. 258
Chapter 24, Drug Therapy for Fungal Infections .......................................................... 270
Chapter 25, Drug Therapy for Parasitic Infections....................................................... 281
Chapter 26, Drug Therapy for Hypertension ................................................................ 292
Chapter 27, Drug Therapy for Dysrhythmias ............................................................... 303
Chapter 28, Drug Therapy for Coronary Heart Disease ............................................... 314
Chapter 29, Drug Therapy for Shock and Hypotension ................................................ 326
Chapter 30, Drug Therapy for Heart Failure ................................................................ 334
Chapter 31, Drug Therapy for Nasal Congestion and Cough ........................................ 345
Chapter 32, Drug Therapy to Decrease Histamine Effects and Allergic Response ....... 358
Chapter 33, Drug Therapy for Asthma, Airway Inflammation, and Bronchoconstriction
...................................................................................................................................... 369
~2~
,THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 34, Drug Therapy for Fluid Volume Excess ..................................................... 379
Chapter 35, Nutritional Support Products, Vitamins, and Mineral Supplements ........ 389
Chapter 36, Drug Therapy for Weight Management ..................................................... 399
Chapter 37, Drug Therapy for Peptic Ulcer Disease and Hyperacidity ........................ 406
Chapter 38, Drug Therapy for Nausea and Vomiting .................................................... 417
Chapter 39, Drug Therapy for Constipation and Elimination Problems ...................... 427
Chapter 40, Drug Therapy for Diarrhea ....................................................................... 438
Chapter 41, Drug Therapy for Diabetes Mellitus .......................................................... 448
Chapter 42, Drug Therapy for Hyperthyroidism and Hypothyroidism ........................ 461
Chapter 43, Drug Therapy for Pituitary and Hypothalamic Dysfunction ..................... 472
Chapter 44, Drug Therapy to Regulate Calcium and Bone Metabolism........................ 483
Chapter 45, Drug Therapy for Adrenal Cortex Disorders ............................................. 494
Chapter 46, Physiology of the Autonomic and Central Nervous Systems and Indications
for the Use of Drug Therapy ......................................................................................... 506
Chapter 47, Drug Therapy for Myasthenia Gravis, Alzheimer‘s Disease, and Other
Conditions Treated with Cholinergic Agents ................................................................ 518
Chapter 48, Drug Therapy for Parkinson‘s Disease, Urinary Spasticity, and Disorders
Requiring Anticholinergic Drug Therapy ..................................................................... 531
Chapter 49, Drug Therapy With Opioids ...................................................................... 544
Chapter 50, Drug Therapy With Local Anesthetics ...................................................... 554
Chapter 51, Drug Therapy With General Anesthetics .................................................. 563
Chapter 52, Drug Therapy for Migraine and Other Headaches .................................... 574
Chapter 53, Drug Therapy for Seizure Disorders and Skeletal Muscle Disorders ....... 585
Chapter 54, Drug Therapy for Anxiety and Insomnia .................................................. 594
Chapter 55, Drug Therapy for Depression and Mood Stabilization ............................. 606
Chapter 56, Drug Therapy for Psychotic Disorders ...................................................... 615
Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy
...................................................................................................................................... 643
Chapter 58: Chapter 58 Drug Therapy for Substance Abuse Disorders ....................... 650
Chapter 59: Drug Therapy for Disorders of the Eye ..................................................... 657
Chapter 60: Drug Therapy for Disorders of the Ear ..................................................... 662
Chapter 61: Drug Therapy for Disorders of the Skin .................................................... 665
~3~
, THIS DOCUMENT BELONGS TO TESTBANKSPROF
Chapter 1 : The Foundation of Pharmacology: Quality and
Safety :
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
paroxetine hydrochloride. What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on symptoms
CORRECT ANSWER: B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the
bloodstream to their sites of action in various body tissues, and eventually eliminated from the
body. Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride
will control the symptoms but not cure the disorder. Drugs with local effects, such as sunscreen
and local anesthetics, act
mainly at the site of application. Paroxetine hydrochloride is not administered parenterally.
Parenteral agents are administered subcutaneously, intramuscularly, or intravenously.
PTS: 1 REF: p. 3, Introduction OBJ: 1
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP:
Chapter: 1: The Foundation of Pharmacology: Quality and Safety
KEY: Integrated Process: Nursing Process
BLM: Cognitive Level: Understand NOT: Multiple Choice
2. A client has been prescribed an antibiotic. This medication is a naturally occurring
substance that has been chemically modified. What is another name for this type of medication?
A. Synthetic drug
B. Semisynthetic drug
C. Biotechnology drug
D. Prototype drug
CORRECT ANSWER: B
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that
have been chemically modified. Synthetic drugs are more standardized in their chemical
characteristics, more consistent in their effects, and less likely to produce allergic reactions.
Biotechnology drugs involve manipulating DNA and RNA and recombining genes into hybrid
molecules that can be inserted into living organisms. Prototype drugs are the first drug of a
particular group to be developed.
~4~